Fact Sheets on Biologic Medicines
Downloads
Report- Factsheet 2: Regulation of Biologics
- Factsheet 3: Introduction to Biosimilars & Regulatory Requirements
- Factsheet 4: Biosimilars and the Importance of Adherence to International regulatory standards
- Factsheet 5: Pharmacovigilance: Monitoring and Traceability across the system
- Factsheet 6: Talking to patients about biosimilars
- Factsheet 7: Regulator capacity for bioligics in low-and-middle income countries
- Factsheet 8: Key recommendations of the WHO biosimilars Evaluation guideleine
- FAQs
- Scorecard to assist in talking with your doctor about biosimilars
Share
Topics
Related news and resources
Pharmacy-mediated substitution for biosimilars
This position paper from IFPMA addresses substitution relating to biosimilars and their reference products at the retail pharmacy level. While this practice has been in place in many countries for generics, for biosimilars, the practice is only emerging.
Read more
Synthetic follow-on products that reference biologically produced medicines
The focus of this paper is follow-on versions of smaller protein products developed to be marketed following expiry of patent and data protection of the reference product. They are synthetically produced while the reference product is manufactured recombinantly.
Read more